Home » Stocks » CMLF

CM Life Sciences, Inc. (CMLF)

Stock Price: $16.41 USD 0.40 (2.50%)
Updated Mar 5, 2021 4:00 PM EST - Market closed
After-hours: $16.97 +0.56 (3.41%) Mar 5, 7:59 PM
Market Cap 908.19M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 44.28M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 5
Last Price $16.41
Previous Close $16.01
Change ($) 0.40
Change (%) 2.50%
Day's Open 16.03
Day's Range 13.67 - 16.58
Day's Volume 3,415,185
52-Week Range 9.66 - 27.18

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 3 weeks ago

NEW YORK, Feb. 12, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities...

PRNewsWire - 3 weeks ago

NEW YORK, Feb. 11, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CM Life Sciences, Inc. ("CMLF...

CNBC Television - 3 weeks ago

Keith Meister, Eli Casdin on new SPAC and data-driven health care

CNBC's "Halftime Report" team discusses the CM Life Sciences SPAC and the future of data-driven health care with Keith Meister of Corvex Capital and Eli Casdin of Casdin Capital.

CNBC Television - 3 weeks ago

Sema4's Eric Schadt on health intelligence and going public via SPAC

CNBC's "Halftime Report" team discusses SPACs and the future of AI and data in the health care sector with Sema4 founder and CEO Eric Schadt. Sema4 is a patient-centered health intelligence co...

InvestorPlace - 3 weeks ago

CM Life Sciences (CMLF) stock is soaring higher on Wednesday after announcing plans to take Sema4 public via a SPAC merger. The post CMLF Stock: 13 Things to Know About CM Life Sciences and th...

Business Wire - 3 weeks ago

NEW YORK & STAMFORD, Conn.--(BUSINESS WIRE)--Sema4, an AI- and machine learning-driven patient-centered genomic and clinical data intelligence company, and CM Life Sciences (Nasdaq: CMLF), a s...

About CMLF

CM Life Sciences intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.

Industry
Shell Companies
IPO Date
Sep 2, 2020
CEO
Eli Decatur Casdin
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
CMLF
Full Company Profile